HomeHealthcareDiagnosticsNeurorehabilitation Market

Neurorehabilitation Market - Strategic Insights and Forecasts (2026-2031)

📥 Download Free Sample💬 Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Report Overview

🎯

Neurorehabilitation Market - Strategic Highlights

Medtronic PLC
Medtronic is a worldwide clinical innovation supplier that gives an exhaustive scope of neurorehabilitation gear and treatments. Neurostimulation frameworks, implantable gadgets, and other new answers for the treatment of neurological ailments are important for their portfolio.
DIH Medical Group
DIH’s subsidiary Hocoma AG manufactures sensor-based neurorehabilitation systems. Automated treatment frameworks, augmented reality stages, and sensor-helped restoration gear for upper and lower appendage recovery are among their contributions.
Saebo Inc.
Saebo is a company that specializes in upper limb rehabilitation equipment and solutions. They provide several goods, including functional orthoses and robotic treatment systems, to help people with neurological problems improve their hand and arm function.

Neurorehabilitation Market Size:

The neurorehabilitation devices market, with a 12.07% CAGR, is expected to grow to USD 3.679 billion in 2031 from USD 1.857 billion in 2025.

Neurorehabilitation alludes to different treatments, mediations, and hardware that are planned to advance utilitarian recuperation, reestablish versatility, and work on personal satisfaction in patients experiencing neurological illnesses or mishaps. Stroke, spinal rope injury, Parkinson's infection, different sclerosis, and different issues might be among them.

The Neurorehabilitation market size is growing quickly, attributable to an expansion in the recurrence of neurological illnesses, mechanical enhancements, and steady government endeavors. As the discipline is created, there is huge potential for extra advances in neurorehabilitation methodology and hardware, eventually prompting improved results and a better life for those with neurological impedances.

Neurorehabilitation Market Growth Drivers:

  • Increasing Prevalence of Neurological Disorders:

As the rate of neurological ailments like stroke, horrendous mind injury, and numerous cases of sclerosis rises, so does the interest in neurorehabilitation medicines. Market expansion is driven by the growing demand for effective rehabilitation solutions from this expanding patient population.

  • Technological Advancements in Rehabilitation Devices:

Advanced rehabilitation technologies like robotic exoskeletons, brain-computer interfaces, and virtual reality systems have revolutionized neurorehabilitation. These state-of-the-art contraptions convey precise and customized treatment activities, tempting medical services experts and impelling business sector development.

  • Growing Focus on Functional Recovery and Quality of Life:

There is a developing accentuation on upgrading practical recuperation and working on personal satisfaction for those with neurological infections. By providing comprehensive rehabilitation programs, neurorehabilitation plays a crucial role in achieving these goals, leading to increased demand and market expansion. 

Neurorehabilitation Market Key Players:

Neurorehabilitation Market Geographical Outlook:

  • North America is anticipated to hold a considerable neurorehabilitation market share.

North America is projected to account for a significant market share which is attributable to various factors. Firstly, the region contains sophisticated healthcare infrastructure, such as specialized rehabilitation centers and research organizations, which encourage the use of neurorehabilitation technology. Also, neurological illnesses are common in North America, increasing the requirement for appropriate rehabilitation methods. Furthermore, favorable reimbursement regulations and government activities promoting neurorehabilitation contribute to the region's neurorehabilitation market share. Furthermore, the presence of significant companies in North America, as well as continuing expenditures in research and development operations, reinforce its market position in the Neurorehabilitation market.

Neurorehabilitation Market Key Developments:

  • In February 2023, Lupin Limited launched the first-of-its-kind computer and robotic-assisted Neurorehabilitation Center “Atharv Ability” in Mumbai. The center would provide rehabilitation programs for patients suffering from spinal cord & brain injury and other neurological conditions such as Parkinson's, multiple sclerosis, and cerebral palsy.

Neurorehabilitation Market Scope:

Report Metric Details
Study Period 2021 to 2031
Historical Data 2021 to 2024
Base Year 2025
Forecast Period 2026 – 2031
Companies
  • Medtronic plc
  • Abbott Laboratories
  • Bionik Laboratories Corp.
  • Ekso Bionics Holdings, Inc.
  • DIH Medical Group
  • ReWalk Robotics
  • BioXtreme Ltd.
  • Kinova
  • Saebo Inc.   

Report Metric

Details

Neurorehabilitation Market Size in 2025

USD 2.229 billion

Neurorehabilitation Market Size in 2030

USD 3.581 billion

Growth Rate

CAGR of 9.95%

Study Period

2020 to 2030

Historical Data

2020 to 2023

Base Year

2024

Forecast Period

2025 – 2030

Forecast Unit (Value)

USD Billion

Segmentation

  • Product

  • Application

  • End-user

  • Geography

Geographical Segmentation

North America, South America, Europe, Middle East and Africa, Asia Pacific

List of Major Companies in Neurorehabilitation Market

  • Medtronic plc

  • Abbott Laboratories

  • Bionik Laboratories Corp.

  • Ekso Bionics Holdings, Inc.

  • DIH Medical Group

Customization Scope

Free report customization with purchase

 

Neurorehabilitation Market Segmentation

  • By Product

    • Neuro-Robotic System

    • Wearable Devices

    • Brain Computer Interface

    • Non-Invasive Stimulators

    • Neuronal Prosthetics

    • Others

  • By Application

    • Stroke

    • Traumatic Brain Injury (TBI)

    • Spinal Cord Injury (SCI)

    • Parkinson's Disease

    • Cerebral Palsy

    • Others

  • By End-User

    • Hospitals

    • Clinics

    • Rehabilitation Centers

    • Home Care Settings

  • By Geography

    • North America

      • USA

      • Canada

      • Mexico

    • South America

      • Brazil

      • Argentina

      • Others

    • Europe

      • Germany

      • France

      • United Kingdom

      • Spain

      • Others

    • Middle East and Africa

      • Saudi Arabia

      • UAE

      • Others

    • Asia Pacific

      • China

      • India

      • Japan

      • South Korea

      • Indonesia

      • Thailand

      • Others

REPORT DETAILS

Report ID:KSI061615682
Published:Jan 2026
Pages:151
Format:PDF, Excel, PPT, Dashboard
📥 Download Sample📞 Speak to Analyst📧 Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us

Frequently Asked Questions

The neurorehabilitation market is expected to reach a total market size of USD 3.581 billion by 2030.

Neurorehabilitation Market is valued at USD 2.229 billion in 2025.

The neurorehabilitation market is expected to grow at a CAGR of 9.95% during the forecast period.

The Neurorehabilitation market growth is expanding steadily as the frequency of neurological illnesses rises and the demand for effective rehabilitation methods rises.

The North American region is anticipated to hold a significant share of the neurorehabilitation market.

Related Reports

Healthcare

Smart Structural Health Monitoring Market - Forecasts from 2026 to 2031

Jan 2026
Healthcare

Taiwan RUO Immunoassay Market Size, Share, Opportunities, And Trends By Product Type (Immunoassay Kits, Immunoassay Reagents, Microplate Reader, Microplates, Analyzers (Automated Analyzers, Non-Automated Analyzers), Microplate Washers, Others), By Sample Type (Plasma, Blood Serum, Urine, Saliva, Cell or Tissue Culture Medium, Others), By Application (Oncology, Blood Screening and Toxicology, Infectious Disease, Cardiology, Allergy Diagnostic, Rare and Emerging Condition Diagnostic, Others), And By End-User (Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies) - Forecasts From 2025 To 2030

Jun 2025
Healthcare

Indonesia RUO Immunoassay Market Size, Share, Opportunities, And Trends By Product Type (Immunoassay Kits, Immunoassay Reagents, Microplate Reader, Microplates, Analyzers (Automated Analyzers, Non-Automated Analyzers), Microplate Washers, Others), By Sample Type (Plasma, Blood Serum, Urine, Saliva, Cell or Tissue Culture Medium, Others), By Application (Oncology, Blood Screening and Toxicology, Infectious Disease, Cardiology, Allergy Diagnostic, Rare and Emerging Condition Diagnostic, Others), By End-User (Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies), And By City - Forecasts From 2025 To 2030

Jun 2025
Healthcare

South Korea RUO Immunoassay Market Size, Share, Opportunities, And Trends By Product Type (Immunoassay Kits, Immunoassay Reagents, Microplate Reader, Microplates, Analyzers (Automated Analyzers, Non-Automated Analyzers), Microplate Washers, Others), By Sample Type (Plasma, Blood Serum, Urine, Saliva, Cell or Tissue Culture Medium, Others), By Application (Oncology, Blood Screening and Toxicology, Infectious Disease, Cardiology, Allergy Diagnostic, Rare and Emerging Condition Diagnostic, Others), By End-User (Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies), And By State - Forecasts From 2025 To 2030

Jun 2025
View All Reports